Application of the International System for Reporting Serous Fluid Cytopathology to pericardial fluid: Root cause analysis of indeterminate diagnoses, cytohistological correlation, and assessment of malignancy risk
Cancer Cytopathology · 2023-07 · 131 (7) · 433-441
DOI: 10.1002/cncy.22696 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cytopathology, online erschienen am 27.03.2023. Verfasst von Minhua Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Yale School of Medicine, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Neoplasms, Pericardial Effusion. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Departmental Research Histology Fund of the Yale School of Medicine.
Abstract (Originalsprache)
Background
This study investigates the utility of the International System for Reporting Serous Fluid Cytopathology (ISRSFC) in the categorization of pericardial fluid and assesses the diagnostic performance and risk of malignancy (ROM) for each of the diagnostic categories.
Methods
All pericardial fluid cases at the Yale School of Medicine between January 1, 2017, and December 31, 2020, were reviewed. The diagnoses were reclassified into five categories according to the ISRSFC: nondiagnostic (ND), negative for malignancy (NFM), atypia of uncertain significance (AUS), suspicious for malignancy (SFM), and malignant (MAL). ROM and performance parameters of each category were calculated.
Results
After reclassification, the distribution of 465 pericardial fluid cases in each category was as follows: ND, 19 (4.1%); NFM, 332 (71.4%); AUS, 21 (4.5%); SFM, 11 (2.4%); and MAL, 82 (17.6%). Confirmatory follow‐ups were available for 16 ND (66.7%), 299 NFM (90%), 15 AUS (71%), 5 SFM (45.5%), and 30 MAL cases (36.6%). The ROM was 0% for ND, 1.3% for NFM (4 of 332), 20% for AUS (3 of 15), and 100% for both SFM (5 of 5) and MAL (27 of 27). The diagnostic performance was as follows: sensitivity, 87% (27 of 31); specificity, 100% (292 of 292); positive predictive value (PPV), 100% (27 of 27); negative predictive value (NPV), 98.6% (292 of 296); and diagnostic accuracy, 98.8% (319 of 323).
Conclusions
The ISRSFC is a highly useful system for the reporting of pericardial fluid and risk assessment, given that it offers high sensitivity, specificity, PPV, NPV, and diagnostic accuracy. The application of this system may help to better categorize pericardial fluid and facilitate the standardization of cytopathology reporting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Yale School of Medicine, New Haven, Connecticut, USA.
ORCID-Profile: Tong Sun
Förderung
- Departmental Research Histology Fund of the Yale School of Medicine
Zitieren
APA
Wang, M., Sun, T., Jiao, J., & Wang, H. (2023). Application of the International System for Reporting Serous Fluid Cytopathology to pericardial fluid: Root cause analysis of indeterminate diagnoses, cytohistological correlation, and assessment of malignancy risk. Cancer Cytopathology, 131(7), 433-441. https://doi.org/10.1002/cncy.22696
Vancouver
Wang M, Sun T, Jiao J, Wang H. Application of the International System for Reporting Serous Fluid Cytopathology to pericardial fluid: Root cause analysis of indeterminate diagnoses, cytohistological correlation, and assessment of malignancy risk. Cancer Cytopathology. 2023;131(7):433-441. doi:10.1002/cncy.22696
BibTeX
@article{Wang2023,
author = {Wang, Minhua and Sun, Tong and Jiao, Jingjing and Wang, He},
title = {Application of the International System for Reporting Serous Fluid Cytopathology to pericardial fluid: Root cause analysis of indeterminate diagnoses, cytohistological correlation, and assessment of malignancy risk},
journal = {Cancer Cytopathology},
year = {2023},
volume = {131},
number = {7},
pages = {433--441},
doi = {10.1002/cncy.22696}
}
EUVIMED